Results 21 to 30 of about 1,069,547 (329)

“Low Dose MR” Dixon Technique for Imaging FDG PET-MR Lymphoma

World Journal of Nuclear Medicine, 2022
Introduction Hybrid PET-MR is a relatively new imaging modality with its major strength being the MR component offering superior soft tissue contrast. While PET/MRI offers the inherent advantage of reduced radiation dose, it has been shown to result in a
Musa Ali Mufti, Robert Matthews, Ezemonye Madu, Kavitha Yaddanapudi, Dinko Franceschi   +4 more
doaj   +1 more source

Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study

European Journal of Nuclear Medicine and Molecular Imaging, 2020
Purpose Glioma treatment planning requires precise tumor delineation, which is typically performed with contrast-enhanced (CE) MRI. However, CE MRI fails to reflect the entire extent of glioma.
Shuangshuang Song, Ye Cheng, Jie Ma, Leiming Wang, Chengyan Dong, Yukui Wei, Geng Xu, Y. An, Zhigang Qi, Qingtang Lin, Jie Lu   +10 more
semanticscholar   +1 more source

NEMA NU 2-2007 performance characteristics of GE Signa integrated PET/MR for different PET isotopes [PDF]

, 2019
BackgroundFully integrated PET/MR systems are being used frequently in clinical research and routine. National Electrical Manufacturers Association (NEMA) characterization of these systems is generally done with F-18 which is clinically the most relevant
D'Asseler, Yves, De Vasconcelos Caribé, Paulo Rauli Rafeson, Deller, Timothy W, Koole, M., Van Laere, K, Vandenberghe, Stefaan   +5 more
core   +1 more source

PET/MR outperforms PET/CT in suspected occult tumors [PDF]

, 2017
BACKGROUND To compare the diagnostic accuracy of PET/MR and PET/CT in patients with suspected occult primary tumors. METHODS This prospective study was approved by the institutional review board. Sequential PET/CT-MR was performed in 43 patients (22 male
Burger, Irene A, De Galiza Barbosa, Felipe, Delso, Gaspar, Huellner, Martin W, Mader, Cäcilia E, Sah, Bert-Ram, Sekine, Tetsuro, Stolzmann, Paul, Ter Voert, Edwin E, Veit-Haibach, Patrick, von Schulthess, Gustav K   +10 more
core   +1 more source

Design and system evaluation of a dual-panel portable PET (DP-PET)

EJNMMI Physics, 2021
Background Integrated whole-body PET/MR technology continues to mature and is now extensively used in clinical settings. However, due to the special design architecture, integrated whole-body PET/MR comes with a few inherent limitations.
Tianyi Zeng, Jiaxu Zheng, Xinyuan Xia, Xin Chen, Beien Wang, Shuangyue Zhang, Adam Chandler, Tuoyu Cao, Lingzhi Hu, Qun Chen, Xu Chu   +10 more
doaj   +1 more source

Non-small-cell lung cancer resectability: diagnostic value of PET/MR. [PDF]

, 2014
Purpose To assess the diagnostic performance of PET/MR in patients with non-small-cell lung cancer. Methods Fifty consecutive consenting patients who underwent routine 18F-FDG PET/CT for potentially radically treatable lung cancer following a staging ...
Barnes, A, Bomanji, JB, Fraioli, F, Groves, AM, Janes, SM, Kayani, I, Menezes, L, O'Meara, C, Punwani, S, Screaton, NJ, Syed, R, Win, T, Zaccagna, F   +12 more
core   +2 more sources

In-line high resolution PET and 3T MRI hybrid device for preclinical multimodal imaging [PDF]

, 2014
Proocedings of: 3rd Conference on PET/MR and SPECT/MR (PSMR 2014).
Cusso Mula, Lorena, Desco Menéndez, Manuel, García Vázquez, Verónica, Montesinos, P., Vaquero López, Juan José   +4 more
core   +3 more sources

Human Papillomavirus Status and the Risk of Cerebrovascular Events Following Radiation Therapy for Head and Neck Cancer

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundRadiation therapy (RT) is a standard treatment for head and neck cancer; however, it is associated with inflammation, accelerated atherosclerosis, and cerebrovascular events (CVEs; stroke or transient ischemic attack). Human papillomavirus (HPV)
Daniel Addison, Sara B. Seidelmann, Sumbal A. Janjua, Hamed Emami, Pedro V. Staziaki, Travis R. Hallett, Bálint Szilveszter, Michael T. Lu, Richard P. Cambria, Udo Hoffmann, Annie W. Chan, Lori J. Wirth, Tomas G. Neilan   +12 more
doaj   +1 more source

Comparison of Nasopharyngeal MR, 18 F-FDG PET/CT, and 18 F-FDG PET/MR for Local Detection of Natural Killer/T-Cell Lymphoma, Nasal Type

Frontiers in Oncology, 2020
ObjectivesThe present study aims to compare the diagnostic efficacy of MR, 18F-FDG PET/CT, and 18F-FDG PET/MR for the local detection of early-stage extranodal natural killer/T-cell lymphoma, nasal type (ENKTL).Patients and MethodsThirty-six patients ...
Rui Guo, Pengpeng Xu, Shu Cheng, Mu Lin, Huijuan Zhong, Weixia Li, Hengye Huang, Bingsheng Ouyang, Hongmei Yi, Jiayi Chen, Xiaozhu Lin, Kuangyu Shi, Kuangyu Shi, Weili Zhao, Biao Li   +14 more
doaj   +1 more source

CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer [PDF]

, 2019
Background: Molecular targeting remains to be a promising approach in oncology. Overexpression of G protein-coupled receptors (GPCRs) in human cancer is offering a powerful opportunity for tumor-selective imaging and treatment employing nuclear medicine.
Bandholtz, Sebastian, Beindorff, Nicola, Brenner, Winfried, Erdmann, Sarah, Exner, Samantha, Grötzinger, Carsten, Gómez, Juan Daniel Castillo, Hacht, Jan Lennart von, Koziolek, Eva Jolanthe, Niederstadt, Lars, Prasad, Sonal, Reinicke, Sandy, Wagener, Asja   +12 more
core   +1 more source